![](/img/cover-not-exists.png)
Phase II study of high-sensitivity genotyping of KRAS , NRAS , BRAF and PIK3CA to ultra-select metastatic colorectal cancer patients for panitumumab plus FOLFIRI: the ULTRA trial
Santos, C, Azuara, D, Viéitez, J M, Páez, D, Falcó, E, Élez, E, López-López, C, Valladares, M, Robles-Díaz, L, García-Alfonso, P, Bugés, C, Durán, G, Salud, A, Navarro, V, Capellá, G, Salazar, R, AranLanguage:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz082
Date:
March, 2019
File:
PDF, 627 KB
english, 2019